| KN2 Research for Universal Health Coverage; Perspective on Vaccines and Poverty Reduction | Margaret Chan, Tim Evans | 2000 | Report | Anglais |
| W8 Systems Vaccinology | Ingileif Jonsdottir | | Report | Anglais |
| W6 Innovation in vaccine delivery and presentation: How can technological advances increase program performance? | M. Gottlieb, R. Lagos | | Report | Anglais |
| P7 Innovative vaccine research: the point of view of industry and biotech companies | Michael Mowatt, Odile Leroy | | Report | Anglais |
| W7 Contributions of Regulatory Science to Vaccine Access | Helen Rees, Norman Baylor | | Report | Anglais |
| KN3-1 The Importance of Innovation in Addressing Global Health Gaps in the Developing World | Trevor Mundel | | Presentation | Anglais |
| KN3 Importance of Innovation in Addressing Global Health Gaps in the Developing World | Trevor Mundel | | Report | Anglais |
| P6 Protection of pregnant women, neonates and infants by maternal immunization | Helen Rees | 2014 | Report | Anglais |
| P5 Research to improve monitoring and evaluation of immunization programs | Jean-Marie Okwo-Bele | 2014 | Report | Anglais |
| P3 Developing Next Generation Vaccines: Defining the Improvements Needed and Evaluating Their Potential | K. Neuzil | 2014 | Report | Anglais |
| P2 Regulatory and Public Health Challenges for Vaccines Inducing Modest Efficacy | David Salisbury | 2014 | Report | Anglais |
| Agenda - GVIRF 2014 | GVIRF Secretariat | 2014 | Presentation | Anglais |
| W8.3 Application of technological advances to clinical trials | Willem Hanekom | 2014 | Presentation | Anglais |
| W8.2 Systems Vaccinology | Bali Pulendran | 2014 | Presentation | Anglais |
| W8.1 How can recent technological advances in systems vaccinology accelerate next-generation vaccine development? | Ingileif Jonsdottir | 2014 | Presentation | Anglais |
| W7.3 How can innovation in regulatory science inform the regulatory process to facilitate the development of new vaccines? | Marion Gruber | 2014 | Presentation | Anglais |
| W7.2 Enhancement in Laboratory Research to Support Innovations in Regulatory Science for the Evaluation of New Vaccines | Teeranart Jivapaisarnpong | 2014 | Presentation | Anglais |
| W7.1 Contributions of Regulatory Science to Vaccine Access | Norman W. Baylor | 2014 | Presentation | Anglais |
| W6.3 Case Study: The Uniject Injection System | Debra Kristensen | 2014 | Presentation | Anglais |
| W6.2 Beyond the cold chain… Meningitis A conjugate vaccine in a controlled temperature chain: Experience from Benin | Olivier Ronveaux | 2014 | Presentation | Anglais |
| W6.1 WHO - Next-generation Vaccine Delivery Technology Meeting Summary | Darin Zehrung | 2014 | Presentation | Anglais |
| W5.4 Building Implementation Research Capacity for Polio Eradication | Margaret Gyapong | 2014 | Presentation | Anglais |
| W5.3 Strengthening national capacity for evidence-based immunization policy: the case of program costing in Honduras | Cara Bess Janusz | 2014 | Presentation | Anglais |
| W5.2 Factors influencing community health volunteers in participating in health programs in Africa | Fadima YAYA BOCOUM | 2014 | Presentation | Anglais |
| W5.1 Immunization implementation research priority setting | John Clemens | 2014 | Presentation | Anglais |
| W4.2 Prioritizing the Research Agenda for Measles and Rubella | William Moss | 2014 | Presentation | Anglais |
| W4.1 Progress, Challenges, and Lessons Learned in Achieving Measles and Rubella Goals | Thomas Cherian | 2014 | Presentation | Anglais |
| W3.2 Pre-exposure rabies vaccination (PreP) in children of endemic countries | D. Briggs | 2014 | Presentation | Anglais |
| W3.1 Leishmania Vaccine Development: Progress and challenges in the context of other control strategies | Farrokh Modabber | 2014 | Presentation | Anglais |
| W2.3 Group A streptococcal vaccines: Challenges and progress | Florian Schödel | 2014 | Presentation | Anglais |
| W2.2 RSV Vaccine Development for Low and Middle Income Countries: Challenges and Progress | Claudio Lanata | 2014 | Presentation | Anglais |
| W2.1 WHO Preferred Product Characteristics: Bridging Vaccine R&D with Public Health | Vasee Moorthy | 2014 | Presentation | Anglais |
| W1.1 Towards the Development of a Universal Influenza Vaccine | David Spiro | 2014 | Presentation | Anglais |
| P7.1 Innovation for vaccines against poverty diseases: the need for new support mechanisms | Martin Friede | 2014 | Presentation | Anglais |
| P6.2 Maternal Immunization: which impact on infant immunity? | Claire-Anne Siegrist | 2014 | Presentation | Anglais |
| P6.1 Public Health Benefits of Maternal Immunization | Keith Klugman | 2014 | Presentation | Anglais |
| P5.2 Influenza Vaccine Use in the Americas: Network for Evaluation of Influenza Vaccine Effectiveness REVELAC-1 | Alba María Ropero-Álvarez | 2014 | Presentation | Anglais |
| P5.1 Immunization Registries in Latin America and the Caribbean | M. Carolina Danovaro-Holliday | 2014 | Presentation | Anglais |
| P3.4 Evaluation of the Next Generation of Rotavirus Vaccines | Kathleen Neuzil | 2014 | Presentation | Anglais |
| P3.3 Developing Next Generation Rotavirus Vaccines: Prospects from the Pipeline to Address Remaining Public Health Needs | Mary K. Estes | 2014 | Presentation | Anglais |
| P3.2 Developing Country Vaccine Manufacturers - Access to Immunization | Umesh Parashar | 2014 | Presentation | Anglais |
| P3.1 Developing next generation vaccines: Introduction | Kathleen Neuzil | 2014 | Presentation | Anglais |
| P2.2 Regulatory Considerations for Determining Vaccine Efficacy | Marion Gruber | 2014 | Presentation | Anglais |
| P2.1 Regulatory and public health challenges | Peter Smith | 2014 | Presentation | Anglais |
| P1c.2 Progress towards the development of a malaria vaccine: discussion | Peter Smith | 2014 | Presentation | Anglais |
| P1c.1 Progress towards the development of a malaria vaccine | Ashley Birkett | 2014 | Presentation | Anglais |
| P1b.2 TB Vaccine Development: Challenges & Opportunities | Uli Fruth | 2014 | Presentation | Anglais |
| P1b.1 Update on Tuberculosis Vaccines - 2014 | Tom Evans | 2014 | Presentation | Anglais |
| P1a.2 Progress towards the development of an HIV vaccine: Discussion | José Esparza | 2014 | Presentation | Anglais |
| P1a.1 Status of HIV Vaccine Research & Development | Wayne Koff | 2014 | Presentation | Anglais |
